| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.23 | 1e-08 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.18 | 5e-06 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.25 | 1e-05 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-05 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-05 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-05 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-05 |